730 Third Avenue,
New York , NY, 10017-3206
New York , NY, 10017-3206
Summary
The fund’s objective is to generate total return through investing in international markets outside the United States.
The investment process focuses on companies included in MSCI EAFE Index covering the regions of Western Europe, Australia and Far East. The fund looks at companies across all market capitalization but most of the investments are in the large- and mid-capitalization stocks.
The fundamental research dri More
Link
Directors
Jan 16, 2024- Thomas J. Kenny
- Forrest C. Berkley
- Janice C. Eberly
- Howell E. Jackson
- Michael A. Forrester
- Joseph A. Boateng
- Loren M. Starr
- Nicole Thorne Jenkins
- Joseph A. Carrier
- James M. Poterba
- Nancy A. Eckl
Chief Compliance Officer
- Richard S. Biegen
Fund Manager(s)
- John Tribolet
- Gregory Mancini
Price
- 52-Week High/Low
- $15.36 - $13.27
- Turnover
- 28%
- Expense Ratio
- 0.71%
Company Name |
Holding |
| Novo Nordisk A/S | 5.19 % |
| Sumitomo Mitsui Financial Group Inc | 3.35 % |
| Hitachi Ltd | 3.09 % |
| Shell PLC | 3.07 % |
| AstraZeneca PLC | 2.93 % |
| Daiichi Sankyo Co Ltd | 2.85 % |
| Mitsubishi UFJ Financial Group Inc | 2.79 % |
| Toyota Motor Corp | 2.72 % |
| Novartis AG | 2.5 % |
| Airbus SE | 2.47 % |
| More | 2.47 % |
Documents
Performance
YTD
-
3 Year
-5.85%
5 Year
16.41%
Best
39.59%
2003
Worst
-49.68%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 8% | 8% | -10.7% | 0.7% | -24.9% | 9.8% | -1.3% | 9.1% | -1% |
| Q2 | - | 0.4% | 3.7% | -12.9% | 8.2% | 20.9% | 1.6% | -2.3% | 8.6% | -2% |
| Q3 | - | - | -4.3% | -9.7% | -3.4% | 7.1% | -1.7% | -2% | 7.2% | 7.6% |
| Q4 | - | - | 7.6% | 15.3% | 2.4% | 17.7% | 8.6% | -17.5% | 4.6% | -4.1% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 0.5% | 3.2% | 4% | -3.8% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 5% | 14% | -19% | 8% | 14% | 21% | 0% | 33% | 0% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| TRERX | - | 5% | 14% | -19% | 8% | 14% | 21% | - | 33% | 0% |
| S&P 500 | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% | 10% |
| Alpha | - | 5% | 14% | 2% | -19% | -2% | -8% | - | 13% | -9% |